CLEVELAND (November 14, 2016) – ExactCare® Pharmacy has earned a prominent place on the Crain’s 52 list of fastest-growing privately companies in Northeast Ohio for the third consecutive year, ranking fourth among the 2016 recipients.
Crain’s 52 recognizes companies for entrepreneurial spirit, innovative business tactics and high-speed revenue growth. Winning companies are chosen based on a combination of revenue growth and total revenue.
“This year’s list of Crain’s 52 recipients is comprised of an impressive list of Northeast Ohio companies. We are honored to be among them,” said Dale Wollschleger, RPh, President & CEO.
Wollschleger founded ExactCare in 2009, growing the company from three to nearly 300 employees in just six years. In 2015, the company embarked on its third major expansion, moving into a new 75,000-square-foot facility and investing in proprietary pharmacy technology to enhance its processes and expand capacity. In 2016, ExactCare launched MyECP, a web portal and mobile app providing patients and their care team members direct access to medication information, account details and a number of self-service options.
“ExactCare is a patient first company. Everything we do is focused on what is best for patients and how we can make their experience better. My philosophy is we you do what’s right for our patients, everything else will fall into place for the business,” said Wollschleger.
About ExactCare Pharmacy
ExactCare is a full-service pharmacy that specializes in medication management for patients with multiple disease states and on multiple medications. Our comprehensive pharmacy solution includes a unique in-home patient assessment; medication reconciliation and medication therapy management performed by clinical pharmacists; ongoing refill management; customized adherence packaging; and home delivery. ExactCare’s case-management approach to pharmacy delivers a long-term care level of service to patients in their homes—helping them overcome the challenges of polypharmacy and healthcare providers and payers achieve better clinical and economic outcomes.